Insider Selling: Quanterix Corp (NASDAQ:QTRX) CEO Sells $84,009.32 in Stock

Quanterix Corp (NASDAQ:QTRX) CEO E Kevin Hrusovsky sold 2,636 shares of the stock in a transaction dated Tuesday, July 21st. The stock was sold at an average price of $31.87, for a total transaction of $84,009.32. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

E Kevin Hrusovsky also recently made the following trade(s):

  • On Thursday, July 16th, E Kevin Hrusovsky sold 4,500 shares of Quanterix stock. The shares were sold at an average price of $27.94, for a total transaction of $125,730.00.
  • On Tuesday, June 23rd, E Kevin Hrusovsky sold 5,000 shares of Quanterix stock. The stock was sold at an average price of $27.07, for a total transaction of $135,350.00.
  • On Thursday, June 18th, E Kevin Hrusovsky sold 5,500 shares of Quanterix stock. The shares were sold at an average price of $26.88, for a total transaction of $147,840.00.
  • On Wednesday, June 3rd, E Kevin Hrusovsky sold 5,000 shares of Quanterix stock. The stock was sold at an average price of $27.49, for a total value of $137,450.00.
  • On Monday, June 1st, E Kevin Hrusovsky sold 3,331 shares of Quanterix stock. The shares were sold at an average price of $27.32, for a total value of $91,002.92.
  • On Tuesday, May 26th, E Kevin Hrusovsky sold 5,000 shares of Quanterix stock. The shares were sold at an average price of $25.64, for a total value of $128,200.00.
  • On Monday, May 11th, E Kevin Hrusovsky sold 5,000 shares of Quanterix stock. The stock was sold at an average price of $27.47, for a total value of $137,350.00.
  • On Wednesday, May 6th, E Kevin Hrusovsky sold 5,000 shares of Quanterix stock. The shares were sold at an average price of $27.09, for a total value of $135,450.00.
  • On Friday, May 1st, E Kevin Hrusovsky sold 3,399 shares of Quanterix stock. The stock was sold at an average price of $25.44, for a total transaction of $86,470.56.

Quanterix stock opened at $27.15 on Friday. Quanterix Corp has a fifty-two week low of $10.90 and a fifty-two week high of $32.82. The company has a debt-to-equity ratio of 0.06, a quick ratio of 6.17 and a current ratio of 6.80. The stock has a market cap of $768.62 million, a P/E ratio of -16.86 and a beta of 1.77. The firm’s fifty day moving average price is $27.41 and its 200-day moving average price is $24.58.

Quanterix (NASDAQ:QTRX) last released its earnings results on Tuesday, May 5th. The company reported ($0.39) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.36) by ($0.03). Quanterix had a negative net margin of 70.51% and a negative return on equity of 36.97%. The firm had revenue of $15.73 million during the quarter, compared to the consensus estimate of $12.70 million. On average, analysts predict that Quanterix Corp will post -1.67 earnings per share for the current year.

QTRX has been the topic of a number of analyst reports. Zacks Investment Research lowered shares of Quanterix from a “buy” rating to a “hold” rating in a report on Wednesday, June 10th. BidaskClub lowered Quanterix from a “sell” rating to a “strong sell” rating in a research note on Friday, May 15th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $32.33.

Several hedge funds and other institutional investors have recently made changes to their positions in QTRX. Macquarie Group Ltd. lifted its position in Quanterix by 18.8% in the 4th quarter. Macquarie Group Ltd. now owns 1,337,857 shares of the company’s stock worth $31,614,000 after buying an additional 211,947 shares during the last quarter. BlackRock Inc. raised its stake in shares of Quanterix by 2.5% during the first quarter. BlackRock Inc. now owns 1,233,402 shares of the company’s stock worth $22,659,000 after acquiring an additional 29,680 shares in the last quarter. Frontier Capital Management Co. LLC lifted its holdings in shares of Quanterix by 58.7% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 837,220 shares of the company’s stock worth $22,931,000 after acquiring an additional 309,584 shares during the last quarter. Ashford Capital Management Inc. lifted its holdings in shares of Quanterix by 5.0% in the 1st quarter. Ashford Capital Management Inc. now owns 652,524 shares of the company’s stock worth $11,987,000 after acquiring an additional 31,010 shares during the last quarter. Finally, Silvercrest Asset Management Group LLC boosted its stake in shares of Quanterix by 16.3% in the 1st quarter. Silvercrest Asset Management Group LLC now owns 274,373 shares of the company’s stock valued at $5,040,000 after purchasing an additional 38,357 shares in the last quarter. 69.28% of the stock is currently owned by institutional investors.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, develops and markets ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Simoa HD-1 instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.

Recommended Story: Stock Split

Insider Buying and Selling by Quarter for Quanterix (NASDAQ:QTRX)

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.